Abstract

The mutagenic activity of the drug based on strains of lactic acid and propionic acid microorganisms showed that the studied drug and its metabolites did not induce reverse mutations from histidine auxotrophy to prototrophy in histidine-dependent Salmonella typhimurium TA98 and TA100 strains. The number of revertant colonies in the experiment and control differed significantly less than 2.0 times. The drug had a low MI of 1.0-1.1 for the TA98 strain and 0.96-1.07 for the TA100 strain. The data obtained indicate the safety of the drug based on lactic acid and propionic acid microorganisms, as well as the possibility of its further use in agriculture and veterinary medicine.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.